Kinesophobia's Impact on Hand Tendon Rehabilitation
Launched by ANKARA TRAINING AND RESEARCH HOSPITAL · Dec 17, 2024
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
Patients who underwent primary repair of flexor and/or extensor tendons were included in the study. Data from patients treated with a staged rehabilitation program beginning with passive mobilization in the first week and incorporating electrotherapy and in-person physiotherapy starting from the sixth week were retrospectively analyzed. Patients were grouped as high kinesiophobia (TKS ≥37) or low kinesiophobia (TKS \<37) based on their 6th-week assessment. Total Active Motion (TAM) score, Visual Analog Scale (VAS), grip strength, Hand Functional Index (HFI), and Tampa Kinesiophobia Scale (T...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Clinical diagnosis of underwent primary repair for flexor and/or extensor tendon injuries
- Exclusion Criteria:
- • Patients with associated fractures
- • Peripheral nerve and vascular injuries
- • Rheumatoid arthritis
- • Diabetes mellitus
- • Peripheral artery disease
- • Other rheumatic diseases affecting the hand
About Ankara Training And Research Hospital
Ankara Training and Research Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to enhancing patient outcomes by exploring new therapies and medical interventions across a variety of disciplines. With state-of-the-art facilities and a multidisciplinary team of experienced professionals, Ankara Training and Research Hospital prioritizes patient safety and ethical standards while contributing to the global body of medical knowledge. Their collaborative approach fosters partnerships with academic institutions and industry stakeholders, ensuring rigorous research methodologies and the effective translation of findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Altindag, Turkey
Patients applied
Trial Officials
Nadide Koca, M.D.
Principal Investigator
Department of Physical Therapy and Rehabilitation, University of Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported